Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Ehninger

Showing results (81-90 of 403) with videos related to

Pageof 41
Sort By:
International Journal of Colorectal Disease|February 24, 2006
Ileal perforation in a patient with Crohn's disease while receiving recombinant human growth hormone therapyGernot W Wolkersdörfer, Stephan Miehlke, Ralph Schneider, et al.
Acta Neuropathologica|March 22, 2002
Physical and functional characterization of the human LGI1 gene and its possible role in glioma developmentDietmar Krex, Martin Hauses, Hella Appelt, et al.
Intensive Care Medicine|September 5, 2002
Outcome and prognostic features of intensive care unit treatment in patients with hematological malignanciesFrank Kroschinsky, Matthias Weise, Thomas Illmer, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 31, 2017
Cancer patients' control preferences in decision making and associations with patient-reported outcomes: a prospective study in an outpatient cancer centerMarkus Schuler, Jan Schildmann, Freya Trautmann, et al.
Clinical Imaging|June 29, 2015
(18)F-FDG PET/MRI for therapy response assessment in sarcoma: comparison of PET and MR imaging resultsMarkus Kajo Schuler, Ivan Platzek, Bettina Beuthien-Baumann, et al.
Cell and Tissue Research|November 24, 2004
Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancerMareike Florek, Michael Haase, Anne-Marie Marzesco, et al.
The Lancet. Oncology|December 27, 2011
Prediction of post-remission survival in acute myeloid leukaemia: a post-hoc analysis of the AML96 trialMarkus Pfirrmann, Gerhard Ehninger, Christian Thiede, et al.
Cytometry. Part B, Clinical Cytometry|March 18, 2009
HLA-DRneg patients without acute promyelocytic leukemia show distinct immunophenotypic, genetic, molecular, and cytomorphologic characteristics compared to acute promyelocytic leukemiaUta Oelschlaegel, Brigitte Mohr, Markus Schaich, et al.
The Prostate|July 24, 2014
Simultaneous targeting of prostate stem cell antigen and prostate-specific membrane antigen improves the killing of prostate cancer cells using a novel modular T cell-retargeting systemClaudia Arndt, Anja Feldmann, Stefanie Koristka, et al.
The Lancet. Oncology|March 9, 2004
Mixed response after allogeneic haemopoietic-cell transplantation for metastatic renal-cell carcinomaMartin Bornhäuser, Ulrich Klenk, Christoph Röllig, et al.
Pageof 41

Showing results (81-90 of 403) with videos related to

Sort By:
Pageof 41
International Journal of Colorectal Disease|February 24, 2006
Ileal perforation in a patient with Crohn's disease while receiving recombinant human growth hormone therapyGernot W Wolkersdörfer, Stephan Miehlke, Ralph Schneider, et al.
Acta Neuropathologica|March 22, 2002
Physical and functional characterization of the human LGI1 gene and its possible role in glioma developmentDietmar Krex, Martin Hauses, Hella Appelt, et al.
Intensive Care Medicine|September 5, 2002
Outcome and prognostic features of intensive care unit treatment in patients with hematological malignanciesFrank Kroschinsky, Matthias Weise, Thomas Illmer, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 31, 2017
Cancer patients' control preferences in decision making and associations with patient-reported outcomes: a prospective study in an outpatient cancer centerMarkus Schuler, Jan Schildmann, Freya Trautmann, et al.
Clinical Imaging|June 29, 2015
(18)F-FDG PET/MRI for therapy response assessment in sarcoma: comparison of PET and MR imaging resultsMarkus Kajo Schuler, Ivan Platzek, Bettina Beuthien-Baumann, et al.
Cell and Tissue Research|November 24, 2004
Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancerMareike Florek, Michael Haase, Anne-Marie Marzesco, et al.
The Lancet. Oncology|December 27, 2011
Prediction of post-remission survival in acute myeloid leukaemia: a post-hoc analysis of the AML96 trialMarkus Pfirrmann, Gerhard Ehninger, Christian Thiede, et al.
Cytometry. Part B, Clinical Cytometry|March 18, 2009
HLA-DRneg patients without acute promyelocytic leukemia show distinct immunophenotypic, genetic, molecular, and cytomorphologic characteristics compared to acute promyelocytic leukemiaUta Oelschlaegel, Brigitte Mohr, Markus Schaich, et al.
The Prostate|July 24, 2014
Simultaneous targeting of prostate stem cell antigen and prostate-specific membrane antigen improves the killing of prostate cancer cells using a novel modular T cell-retargeting systemClaudia Arndt, Anja Feldmann, Stefanie Koristka, et al.
The Lancet. Oncology|March 9, 2004
Mixed response after allogeneic haemopoietic-cell transplantation for metastatic renal-cell carcinomaMartin Bornhäuser, Ulrich Klenk, Christoph Röllig, et al.
Pageof 41